^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

Downregulation of NEK11 is associated with drug resistance in ovarian cancer

Excerpt:
...that the NEK11 mRNA was significantly downregulated in 586 cases of ovarian serous cystadenocarcinomas and cisplatin-resistant A2780 ovarian cancer cells….the first report of the association of NEK11 with drug resistance in cancer…
Secondary therapy:
tamoxifen + goserelin acetate
DOI:
10.3892/ijo.2014.2503